Comparison of adjuvant therapy with tamoxifen and goserelin vs. CMF in premenopausal stage I and II hormone-responsive breast cancer patients: four-year results of Austrian Breast Cancer Study Group (ABCSG) trial 5

R. Jakesz, H. Hausmaninger, H. Samonigg, E. Kubista, D. Depisch, Michael Fridrik, M. Stierer, Michael Gnant, G.G. Steger, R. Kolb,

European Journal of Cancer · 1999 · 72 citations · 0 references

Concepts